COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 177 filers reported holding COHERUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,510,150 | +1413.6% | 671,163 | +1628.1% | 0.00% | – |
| Q2 2023 | $165,843 | -93.5% | 38,839 | -89.6% | 0.00% | -100.0% |
| Q1 2023 | $2,561,532 | +2.1% | 374,493 | +18.2% | 0.00% | 0.0% |
| Q4 2022 | $2,510,062 | -99.9% | 316,927 | +1.8% | 0.00% | -20.0% |
| Q3 2022 | $2,991,526,000 | +2040.1% | 311,293 | +1512.3% | 0.01% | – |
| Q2 2022 | $139,783,000 | -31.6% | 19,307 | +21.9% | 0.00% | – |
| Q1 2022 | $204,404,000 | -56.1% | 15,833 | -45.7% | 0.00% | -100.0% |
| Q4 2021 | $465,202,000 | -52.7% | 29,148 | -52.4% | 0.00% | 0.0% |
| Q3 2021 | $983,147,000 | +199.2% | 61,179 | +157.5% | 0.00% | – |
| Q2 2021 | $328,573,000 | +94.8% | 23,758 | +105.8% | 0.00% | – |
| Q1 2021 | $168,658,000 | +15.1% | 11,544 | +36.9% | 0.00% | – |
| Q4 2020 | $146,513,000 | -46.0% | 8,430 | -43.0% | 0.00% | – |
| Q3 2020 | $271,084,000 | +29.0% | 14,781 | +25.6% | 0.00% | – |
| Q2 2020 | $210,141,000 | -68.0% | 11,766 | -70.9% | 0.00% | -100.0% |
| Q1 2020 | $656,942,000 | +400.2% | 40,502 | +455.2% | 0.00% | – |
| Q4 2019 | $131,346,000 | -32.5% | 7,295 | -24.0% | 0.00% | – |
| Q3 2019 | $194,577,000 | +52.0% | 9,604 | +65.8% | 0.00% | – |
| Q2 2019 | $128,047,000 | -13.1% | 5,794 | -46.3% | 0.00% | – |
| Q1 2019 | $147,271,000 | +163534.4% | 10,797 | +107870.0% | 0.00% | – |
| Q4 2018 | $90,000 | -99.6% | 10 | -99.3% | 0.00% | – |
| Q3 2018 | $23,446,000 | +17.9% | 1,421 | 0.0% | 0.00% | – |
| Q2 2018 | $19,894,000 | -79.2% | 1,421 | -83.6% | 0.00% | – |
| Q1 2018 | $95,638,000 | +36.9% | 8,655 | +9.1% | 0.00% | – |
| Q4 2017 | $69,837,000 | +41.8% | 7,936 | +115.1% | 0.00% | – |
| Q3 2017 | $49,248,000 | -13.0% | 3,689 | -6.4% | 0.00% | – |
| Q2 2017 | $56,582,000 | +2423.7% | 3,943 | +3619.8% | 0.00% | – |
| Q1 2017 | $2,242,000 | -82.5% | 106 | -76.7% | 0.00% | – |
| Q4 2016 | $12,808,000 | -76.3% | 455 | -77.4% | 0.00% | – |
| Q3 2016 | $53,962,000 | +179.3% | 2,015 | +76.1% | 0.00% | – |
| Q2 2016 | $19,322,000 | -81.6% | 1,144 | -75.0% | 0.00% | – |
| Q4 2015 | $105,156,000 | +7.6% | 4,580 | -6.1% | 0.00% | – |
| Q3 2015 | $97,715,000 | +72.3% | 4,876 | +148.5% | 0.00% | – |
| Q2 2015 | $56,702,000 | +1127.8% | 1,962 | +1199.3% | 0.00% | – |
| Q1 2015 | $4,618,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |